Concerns Raised To Global Fund Over Panel On Tiered Medicines Pricing
CAPE TOWN, SOUTH AFRICA - Public groups this week urged Mark Dybul, head of the Geneva-based Global Fund for HIV, Tuberculosis and Malaria, to reconsider the establishment of a panel to look at tiered pricing for middle income countries, potentially allowing companies to charge them higher prices. And separately, activists reported on progress in South Africa's HIV strategy.
